McKesson (MCK) Competitors

Cencora (NYSE:COR) and McKesson (NYSE:MCK) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, community ranking, risk, profitability, valuation and earnings.

Is COR or MCK more profitable?

McKesson has a net margin of 0.77% compared to Cencora's net margin of 0.51%. Cencora's return on equity of 266.62% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.51%	266.62%	4.20%
McKesson	0.77%	-207.50%	5.45%

Which has higher earnings and valuation, COR or MCK?

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$638.56M	74.13	$1.51B	$7.51	31.99
McKesson	$308.95B	0.25	$3.00B	$19.31	31.40

Which has more risk and volatility, COR or MCK?

Cencora has a beta of 0.44, meaning that its stock price is 56% less volatile than the S&P 500. Comparatively, McKesson has a beta of 0.44, meaning that its stock price is 56% less volatile than the S&P 500.

Does the MarketBeat Community prefer COR or MCK?

McKesson received 224 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 74.33% of users gave McKesson an outperform vote while only 65.40% of users gave Cencora an outperform vote.

Company	Underperform	Outperform
Cencora	Outperform Votes 743 65.40%	Underperform Votes 393 34.60%
McKesson	Outperform Votes 967 74.33%	Underperform Votes 334 25.67%

Do analysts rate COR or MCK?

Cencora presently has a consensus target price of $271.20, indicating a potential upside of 12.89%. McKesson has a consensus target price of $631.57, indicating a potential upside of 4.17%. Given Cencora's higher possible upside, research analysts plainly believe Cencora is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
McKesson	0 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.94

Does the media favor COR or MCK?

In the previous week, McKesson had 23 more articles in the media than Cencora. MarketBeat recorded 49 mentions for McKesson and 26 mentions for Cencora. McKesson's average media sentiment score of 1.06 beat Cencora's score of 0.96 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cencora	13 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
McKesson	32 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is COR or MCK a better dividend stock?

Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.9%. McKesson pays an annual dividend of $2.84 per share and has a dividend yield of 0.5%. Cencora pays out 29.3% of its earnings in the form of a dividend. McKesson pays out 14.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has raised its dividend for 15 consecutive years and McKesson has raised its dividend for 17 consecutive years.

Do institutionals and insiders hold more shares of COR or MCK?

97.5% of Cencora shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 15.8% of Cencora shares are held by insiders. Comparatively, 0.1% of McKesson shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

McKesson beats Cencora on 14 of the 21 factors compared between the two stocks.